Literature DB >> 21430060

Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity.

Ying Dang1, Aierken Abudu, Sungmo Son, Elena Harjes, Paul Spearman, Hiroshi Matsuo, Yong-Hui Zheng.   

Abstract

During studies of APOBEC3 (A3) anti-human immunodeficiency virus type 1 (anti-HIV-1) mechanisms, we identified a single cysteine at position 320 (C320) that disrupts A3DE activity. This residue is located in the recently identified DNA binding domain in A3G. Replacing C320 with a corresponding tyrosine from A3F (Y307) increased A3DE antiviral activity more than 20-fold. Conversely, replacing A3F Y307 with a cysteine or inserting a similar cysteine into A3B or A3G disrupted the anti-HIV activity of A3. Further investigation uncovered that C320 significantly reduces A3DE catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430060      PMCID: PMC3094948          DOI: 10.1128/JVI.00243-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G.

Authors:  Kuan-Ming Chen; Natalia Martemyanova; Yongjian Lu; Keisuke Shindo; Hiroshi Matsuo; Reuben S Harris
Journal:  FEBS Lett       Date:  2007-09-07       Impact factor: 4.124

3.  APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.

Authors:  Mark D Stenglein; Reuben S Harris
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

4.  Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.

Authors:  Xiaojun Wang; Yanxing Han; Ying Dang; William Fu; Tao Zhou; Roger G Ptak; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.

Authors:  Ying Dang; Xiaojun Wang; Walter J Esselman; Yong-Hui Zheng
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

6.  Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.

Authors:  Kuan-Ming Chen; Elena Harjes; Phillip J Gross; Amr Fahmy; Yongjian Lu; Keisuke Shindo; Reuben S Harris; Hiroshi Matsuo
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

7.  An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

Authors:  Elena Harjes; Phillip J Gross; Kuan-Ming Chen; Yongjian Lu; Keisuke Shindo; Roni Nowarski; John D Gross; Moshe Kotler; Reuben S Harris; Hiroshi Matsuo
Journal:  J Mol Biol       Date:  2009-04-21       Impact factor: 5.469

8.  Dissecting APOBEC3G substrate specificity by nucleoside analog interference.

Authors:  Jason W Rausch; Linda Chelico; Myron F Goodman; Stuart F J Le Grice
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

9.  Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.

Authors:  Lauren G Holden; Courtney Prochnow; Y Paul Chang; Ronda Bransteitter; Linda Chelico; Udayaditya Sen; Raymond C Stevens; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2008-10-12       Impact factor: 49.962

10.  Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.

Authors:  Ayako Furukawa; Takashi Nagata; Akimasa Matsugami; Yuichirou Habu; Ryuichi Sugiyama; Fumiaki Hayashi; Naohiro Kobayashi; Shigeyuki Yokoyama; Hiroshi Takaku; Masato Katahira
Journal:  EMBO J       Date:  2009-01-15       Impact factor: 11.598

View more
  13 in total

1.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

2.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Authors:  Rebecca M McDougle; Judd F Hultquist; Alex C Stabell; Sara L Sawyer; Reuben S Harris
Journal:  Virology       Date:  2013-03-29       Impact factor: 3.616

3.  DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.

Authors:  Bogdan Polevoda; Rebecca Joseph; Alan E Friedman; Ryan P Bennett; Rebecca Greiner; Thareendra De Zoysa; Ryan A Stewart; Harold C Smith
Journal:  J Biol Chem       Date:  2017-04-05       Impact factor: 5.157

4.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

5.  Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.

Authors:  Nisha K Duggal; Wenqing Fu; Joshua M Akey; Michael Emerman
Journal:  Virology       Date:  2013-06-10       Impact factor: 3.616

6.  The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection.

Authors:  Nisha K Duggal; Harmit S Malik; Michael Emerman
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 7.  Host restriction factors in retroviral infection: promises in virus-host interaction.

Authors:  Yong-Hui Zheng; Kuan-Teh Jeang; Kenzo Tokunaga
Journal:  Retrovirology       Date:  2012-12-20       Impact factor: 4.602

8.  Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.

Authors:  Michel Henry; Christophe Terzian; Martine Peeters; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.

Authors:  Eric W Refsland; Judd F Hultquist; Reuben S Harris
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

10.  Retroelements versus APOBEC3 family members: No great escape from the magnificent seven.

Authors:  Juan F Arias; Takayoshi Koyama; Masanobu Kinomoto; Kenzo Tokunaga
Journal:  Front Microbiol       Date:  2012-08-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.